1. Immune recovery effects of immunopotentiator from Pantoea agglomerans 1 (IP-PA1) on low antibody productions in response to Salmonella enteritidis vaccine and sheep red blood cells in dexamethasone-treated stressed chicken models.
- Author
-
Hebishima T, Matsumoto Y, Soma G, Kohchi C, Watanabe G, Taya K, Hayashi Y, and Hirota Y
- Subjects
- Animals, Antibody Formation, Apoptosis, Chickens, Dexamethasone therapeutic use, Immunosuppression Therapy methods, Immunosuppression Therapy veterinary, Lymphocytes drug effects, Pantoea, Poultry Diseases drug therapy, Sheep, Thymus Gland drug effects, Weight Loss, Enterobacteriaceae Infections immunology, Enterobacteriaceae Infections veterinary, Erythrocyte Transfusion veterinary, Poultry Diseases immunology, Poultry Diseases microbiology, Salmonella enteritidis immunology
- Abstract
Considering the usefulness of the immunopotentiator from Pantoea agglomerans 1 (IP-PA1), which is a purified lipopolysaccharide (LPS) derived from symbiotic gram-negative bacteria of food crops, in controlling immunosuppression in poultry husbandry, in this study, we examined its immune-recovery effects in dexamethasone-treated stressed chicken models. Three-week-old chickens daily administered 10 microg/kg of dexamethasone for 35 days to induce stress showed more whole body weight loss; relative thymic, bursal, and splenic weight losses; and decrease in the number of peripheral blood lymphocytes, as compared with the control chickens on day 35; the IP-PA1-pretreated, dexamethasone-treated chickens showed reduced weight losses. Five- to eight-week-old chickens administered 5 mg/kg of dexamethasone showed excessive apoptosis of thymic and bursal lymphocytes 24 hr after a single dexamethasone treatment; apoptosis was inhibited in the IP-PA1-pretreated, dexamethasone-treated chickens. Chickens daily administered 10 microg/kg of dexamethasone for 35 days and injected with commercial Salmonella Enteritidis (SE) vaccine or sheep red blood cells (SRBC) on days 7 and 21 showed about 8- or 2-fold lower antibody production in response to SE or SRBC, respectively, as compared with the control chickens on day 35; the antibody production in response to SE or SRBC was increased in the IP-PA1-pretreated, dexamethasone-treated chickens. These results indicate that IP-PA1 exerts inhibitory effects on dexamethasone-induced immunosuppression and that it may be useful in controlling immunosuppression in poultry husbandry.
- Published
- 2010
- Full Text
- View/download PDF